logo
Sign in

ABT Stock Price, Chart, Stats & News

158.44B
Market cap
17.46x
Current P/E
16.13x
Forward P/E
2.68%
Dividend yield

ABT chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
55.51%
Operating margin
18.16%
Pretax margin
19.10%
Net margin
14.72%
Effective tax rate
22.94%
ROA
7.52%
ROE
12.89%
D/E
0.29x
Interest coverage ratio
23.60x

ABT valuation

P/E
17.46x
P/S
4.08x
P/B
3.48x
P/CF
18.99x
P/FCF
24.43x
P/OCF
18.99x
PEG
-0.52x
EV multiple
14.97x

About

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine.

Similar securities

Based on sector and market capitalization

Report issue